Dermata Therapeutics Inc. (DRMA)

AI Score

Unlock

0.73

0.02 (2.82%)

At close: Apr 17, 2025, 3:55 PM

0.72

-1.32%

After-hours: Apr 17, 2025, 07:09 PM EDT

Dermata Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	3.16M	6.14M	4.95M	4.73M	7.44M	6.63M	8.44M	8.77M	6.24M	8.07M	10.63M	8.19M	10.8M	12.6M	427.2K	1.33M	530.4K	-1.99M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.98M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	540.5M	n/a	n/a	n/a	703.19M	n/a	n/a	200K	825.13M	n/a	677.8K	265.35K	n/a	-1.99M
Receivables	n/a	n/a	n/a	n/a	8.36K	n/a	n/a	6.36K	12.6K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	37.03K	144.29K	92.9K	n/a	76.29K	67.5K	80.87K	n/a	n/a	n/a	179.59K	55.72K	n/a	687.33K	278.07K	n/a	n/a
Total Current Assets	3.53M	6.69M	5.24M	5.18M	7.98M	7.32M	8.71M	9.3M	6.94M	8.97M	11.03M	9.04M	11.62M	13.69M	1.14M	1.65M	605.45K	1.99M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a	540.5M	n/a	n/a	n/a	703.19M	n/a	n/a	200K	825.13M	n/a	677.8K	265.35K	n/a	-1.99M
Total Assets	3.53M	6.69M	5.24M	5.18M	7.98M	7.32M	8.71M	9.3M	6.94M	8.97M	11.03M	9.04M	11.62M	13.69M	1.14M	1.65M	605.45K	n/a
Account Payables	808.01K	863.6K	1.33M	822.55K	866.03K	474.46K	437.78K	492.87K	496.7K	483.74K	608.81K	662.23K	515.25K	769.86K	881.31K	488.09K	104.28K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	174.84K	174.77K	3.55M	n/a
Other Current Liabilities	731.63K	327.24K	n/a	n/a	n/a	n/a	n/a	131.26K	n/a	n/a	n/a	n/a	0.00	0.00	n/a	n/a	0.00	n/a
Total Current Liabilities	1.97M	1.95M	1.92M	1.37M	1.62M	916.82K	682.86K	1.21M	922.63K	1.5M	1.37M	1.19M	1.52M	1.2M	1.64M	939.18K	3.78M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	1.08M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	1.08M	591.25K	n/a	757.59M	442.36K	245.08K	n/a	496.7K	1.02M	757.66K	662.23K	515.25K	n/a	n/a	n/a	n/a	n/a
Total Liabilities	1.97M	1.95M	1.92M	1.37M	1.62M	916.82K	682.86K	1.21M	922.63K	1.5M	1.37M	1.19M	1.52M	1.2M	1.64M	939.18K	3.78M	n/a
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	174.84K	174.77K	3.55M	n/a
Common Stock	252.00	168.00	69.00	666.00	393.00	319.00	319.00	239.00	1.23K	1.21K	1.01K	833.00	833.00	833.00	191.00	191.00	2.35M	n/a
Retained Earnings	-65.68M	-62.52M	-59.35M	-56.52M	-53.39M	-51.25M	-49.53M	-47.83M	-45.59M	-43.92M	-41.5M	-38.77M	-35.98M	-33.43M	-31.72M	-30.38M	-28.08M	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	0.00	n/a	n/a	n/a	n/a	0.00	n/a	-52.98M	-22.49M
Shareholders Equity	1.56M	4.74M	3.32M	3.81M	6.36M	6.41M	8.03M	8.09M	6.02M	7.47M	9.66M	7.85M	10.11M	45.92M	-505.8K	712K	-28.08M	-210.16K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.98M